Insider Transactions in Q2 2023 at Singular Genomics Systems, Inc. (OMIC)
Insider Transaction List (Q2 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 15
2023
|
Eli N. Glezer Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,500
+0.17%
|
-
|
|
Jun 15
2023
|
Dalen Meeter Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,250
+3.33%
|
-
|
|
Jun 15
2023
|
Sam Ropp Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,188
+50.0%
|
-
|
|
Jun 15
2023
|
Andrew Spaventa Chief Executive Officer |
BUY
Bona fide gift
|
Indirect |
14,583
+0.37%
|
-
|
|
Jun 15
2023
|
Andrew Spaventa Chief Executive Officer |
SELL
Bona fide gift
|
Direct |
14,583
-59.89%
|
-
|
|
Jun 15
2023
|
Andrew Spaventa Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
14,583
+37.46%
|
-
|
|
May 17
2023
|
Eli N. Glezer Chief Scientific Officer |
BUY
Open market or private purchase
|
Direct |
170,000
+3.76%
|
$0
$0.82 P/Share
|